Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

The combination treatment showed a higher response rate but no significant survival benefits.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

JAK inhibitors show promise for treating various skin diseases.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

The combination of encorafenib and binimetinib caused few skin issues.

Astragaloside A may help fight lung cancer by targeting specific proteins.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Ruxolitinib helped a patient with alopecia areata regrow hair.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

EK significantly improved wound healing and reduced infection in burn wounds.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Jiawei Erzhiwan helps hair growth in androgenetic alopecia by affecting specific cell pathways.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.